Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DB3L
|
|||
| Drug Name |
Benzoimidazole derivative 1
|
|||
| Synonyms |
PMID28594589-Compound-TABLE3c6
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Array BioPharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H23BrF2N4O3
|
|||
| Canonical SMILES |
CC(C)(C)OCCONC(=O)C1=CC2=C(C(=C1NC3=C(C=C(C=C3)Br)F)F)N=CN2C
|
|||
| InChI |
1S/C21H23BrF2N4O3/c1-21(2,3)30-7-8-31-27-20(29)13-10-16-19(25-11-28(16)4)17(24)18(13)26-15-6-5-12(22)9-14(15)23/h5-6,9-11,26H,7-8H2,1-4H3,(H,27,29)
|
|||
| InChIKey |
MZHRFHRSYBBMON-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1604812-70-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | ERK activator kinase (MEK) | Target Info | Inhibitor | [1] |
| Target's Patent Info | ERK activator kinase (MEK) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | MEK inhibitors in oncology: a patent review (2015-Present).Expert Opin Ther Pat. 2017 Aug;27(8):887-906. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.